Best Penny Newsletter Brings Life to YaFarm Technologies, Inc. (PINK:YFRM)

As the biotech industry heats up several small cap stocks, another ticker surged in activity after years of zero volumes. YaFarm Technologies, Inc. (PINK:YFRM) joined the team with a bid to offer stem cell therapies, but the main reason is that someone decided to pay $150,000 for a series of mailed promotions, and finally bring investors to this sleeping stock.

Thursday was a correction day for YFRM, as it lost more than 29%, but on it first day of trading it shot up close to 60% and more than 13 million stocks were sold. The company is a pink sheet with alternative filing, and its development depends on the following financials:

• $1,051 cash

• $142,195 current liabilities

• Zero revenues

• $20,281 net loss

The promises for the company rely more on technical analysis and novelty than fundamental strength of this debt-financed enterprise. The Best Penny Newsletter, receiving the larger share of the pump money, $100,000, also claim the company is doing studies and applying treatments at the moment, and not just doing research. The newsletter writers hope the stock follows the pattern of previous picks- but we don’t know if this is generally a good thing.

Also dubious is the company’s claim to have ready and viable stem cell therapies where bigger and better-equipped companies are still carefully researching. Given the recent acquisition of the Integrative Stem Cell Institute, an entity in Cancun, which may allow it to offer unverified and experimental therapies with less regulation. The Institute’s site is completely blank, but on the good site, the hospital building offers a swimming pool and an ocean view. According to the clinic’s Facebook page, it opened only recently, accepting patients for stem cell therapies since December. The clinic’s blog explicitly states the therapies are not FDA reviewed, and along with this it is easy to find ominous stories of patients who visited the Galenia Hospital that houses the stem cell institute.

Given the limited finances of YaFarm itself, it is probable that the barely active pink sheet is acting as a vehicle for the Institute and the Mexican clinic to get exposure to the money of American investors, if not the money of American patients. YaFarm itself lists its activity on the OTC as programming and computer technologies.

If medical vacations in Mexico are not your thing, you may want to look with caution on previous picks by the Best Penny Newsletter. Livewire Ergogenics, Inc. (OTC:LVVV) shot up on a promotional campaign in December, spiking to 25 cents, but retreating quickly by 50% on choppy low-volume trading. Keep in mind this risk before deciding to follow the advice of a paid promoter.